Enteron Therapeutics is an emerging pharmaceutical company specializing in innovative therapies in the treatment of diseases within the gastrointestinal system. Enteron, is a privately held US company engaged in the business of acquiring, developing and commercializing proprietary prescription products with a well-established efficacy and safety profile for products already approved outside the US.

The company strategy is to reduce time-to-market and lower the risk of development costs by creating innovative new uses and re-compositions for products within market segments where there is an unmet medical need. In addition, Enteron plans to bring forward several breakthrough adjunct therapies to enhance the effectiveness of current treatment options available to patients today.